openPR Logo
Press release

Investigation for Investors who lost money with shares of Tengjun Biotechnology Corp. (OTC: TJBH) over potential Wrongdoing

An investigation on behalf of investors in Tengjun Biotechnology Corp. (OTC: TJBH) shares over potential wrongdoing.

An investigation on behalf of investors in Tengjun Biotechnology Corp. (OTC: TJBH) shares over potential wrongdoing.

An investigation was announced over potential breaches of fiduciary duties by certain directors at Tengjun Biotechnology Corp.

Investors who purchased shares of Tengjun Biotechnology Corp. (OTC: TJBH) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Tengjun Biotechnology Corp. directors breached their fiduciary duties and caused damage to the company and its shareholders.

China based Tengjun Biotechnology Corp., through its subsidiaries, engages in producing, packaging, distributing, and marketing featured dandelion teas and water purifiers in the People's Republic of China. On September 5, 2023, Tengjun Biotechnology Corp. announced their previous financial statements on Form 10-K for "the fiscal year ended December 31, 2022, should no longer be relied upon due to accounting methodology errors in such financial statements and that the Board deems it advisable and in the best interests of the Company to restate the financial statements by amending its annual report on Form 10-K for the fiscal year ended December 31, 2022 as soon as reasonably practicable."

Shares of Tengjun Biotechnology Corp. (OTC: TJBH) declined from $34.83 per share on August 18, 2023, to as low as $14.68 per share on September 12, 2023.

Those who purchased shares of Tengjun Biotechnology Corp. (OTC: TJBH) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation for Investors who lost money with shares of Tengjun Biotechnology Corp. (OTC: TJBH) over potential Wrongdoing here

News-ID: 3483339 • Views:

More Releases from Shareholders Foundation, Inc.

Lawsuit Alert: Investors who lost money with shares of Molina Healthcare, Inc. (NYSE: MOH) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Molina Healthcare, Inc. ( …
An investor, who purchased shares of Molina Healthcare, Inc. (NYSE: MOH), filed a lawsuit over alleged violations of Federal Securities Laws by Molina Healthcare, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Molina Healthcare, Inc. (NYSE: MOH) have certain options and for certain investors are short and strict deadlines running. Deadline: December 02, 2025. NYSE: MOH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
CTO Realty Growth, Inc. (NYSE: CTO) Long Term Investor Alert: Investigation of potential Wrongdoing
CTO Realty Growth, Inc. (NYSE: CTO) Long Term Investor Alert: Investigation of p …
An investigation on behalf of current long-term investors in shares of CTO Realty Growth, Inc. (NYSE: CTO) concerning potential breaches of fiduciary duties by certain directors and officers of CTO Realty Growth, Inc. was announced. Investors who are current long term investors in CTO Realty Growth, Inc. (NYSE: CTO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a
Lawsuit filed for Investors who lost money with shares of Marex Group plc (NASDAQ: MRX)
Lawsuit filed for Investors who lost money with shares of Marex Group plc (NASDA …
An investor, who purchased shares of Marex Group plc (NASDAQ: MRX), filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Marex Group plc in connection with certain allegedly false and misleading statements. Investors who purchased a significant amount of shares of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025, have certain options
LifeMD, Inc. (NASDAQ: LFMD) Investor Alert: Deadline in Lawsuit on October 27, 2025
LifeMD, Inc. (NASDAQ: LFMD) Investor Alert: Deadline in Lawsuit on October 27, 2 …
A deadline is coming up on October 27, 2025 in the lawsuit filed for certain investors of LifeMD, Inc. (NASDAQ: LFMD) over alleged securities laws violations by LifeMD, Inc. Investors who purchased shares of LifeMD, Inc. (NASDAQ: LFMD) have certain options and there are strict and short deadlines running. Deadline: October 27, 2025. LifeMD, Inc. (NASDAQ: LFMD) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for Tengjun

Investigation announced for Investors who lost money with shares of Tengjun Biot …
An investigation was announced for investors of Tengjun Biotechnology Corp. (OTC: TJBH) shares over potential securities laws violations by Tengjun Biotechnology Corp. Investors who purchased shares of Tengjun Biotechnology Corp. (OTC: TJBH), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Tengjun Biotechnology Corp. regarding its business, its prospects and